Viewing Study NCT00184366


Ignite Creation Date: 2025-12-24 @ 4:36 PM
Ignite Modification Date: 2026-01-05 @ 6:18 PM
Study NCT ID: NCT00184366
Status: TERMINATED
Last Update Posted: 2012-01-19
First Post: 2005-09-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Classification and Characterization of Patients Treated With Efalizumab for Plaque Psoriasis
Sponsor: Norwegian University of Science and Technology
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module